Exact Mass: 452.2311

Exact Mass Matches: 452.2311

Found 17 metabolites which its exact mass value is equals to given mass value 452.2311, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Delapril

2-[N-(2,3-dihydro-1H-inden-2-yl)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanamido]acetic acid

C26H32N2O5 (452.2311)


   
   

Delapril

Delapril

C26H32N2O5 (452.2311)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Benazepril Ethyl Ester

Benazepril Ethyl Ester

C26H32N2O5 (452.2311)


   

alfentanil hydrochloride

alfentanil hydrochloride

C21H33ClN6O3 (452.2303)


   

Aripiprazole Related CoMpound B

Aripiprazole Related CoMpound B

C26H32N2O5 (452.2311)


   

Indacaterol acetate

Indacaterol acetate

C26H32N2O5 (452.2311)


   

(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

C26H32N2O5 (452.2311)


   

(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester

C26H32N2O5 (452.2311)


   

methyl 5-hydroxy-12-{1-[(3-methylbut-2-enoyl)oxy]ethyl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

methyl 5-hydroxy-12-{1-[(3-methylbut-2-enoyl)oxy]ethyl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C26H32N2O5 (452.2311)


   

n-[2-({4-[(4e)-5-{4-[3-(furan-3-yl)propyl]furan-2-yl}-4-methylpent-4-en-1-yl]furan-2-yl}formamido)ethyl]ethanimidic acid

n-[2-({4-[(4e)-5-{4-[3-(furan-3-yl)propyl]furan-2-yl}-4-methylpent-4-en-1-yl]furan-2-yl}formamido)ethyl]ethanimidic acid

C26H32N2O5 (452.2311)


   

methyl (1r,12r,19r)-5-hydroxy-12-[(1s)-1-[(3-methylbut-2-enoyl)oxy]ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

methyl (1r,12r,19r)-5-hydroxy-12-[(1s)-1-[(3-methylbut-2-enoyl)oxy]ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate

C26H32N2O5 (452.2311)


   

(1s,5'r,12s,13r,16s,18r,20s,21r)-5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-one

(1s,5'r,12s,13r,16s,18r,20s,21r)-5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-one

C26H32N2O5 (452.2311)


   

5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-one

5'-(hydroxymethyl)-3,16,23-trimethyl-15,17-dioxa-3,23-diazaspiro[hexacyclo[10.10.1.0²,¹⁰.0⁴,⁹.0¹³,²¹.0¹⁶,²⁰]tricosane-18,2'-oxolane]-2(10),4,6,8-tetraen-3'-one

C26H32N2O5 (452.2311)


   

methyl 6-[(1s,2r)-1-hydroxy-3-methoxy-2-octyl-3-oxopropyl]phenazine-1-carboxylate

methyl 6-[(1s,2r)-1-hydroxy-3-methoxy-2-octyl-3-oxopropyl]phenazine-1-carboxylate

C26H32N2O5 (452.2311)


   

methyl 6-(1-hydroxy-3-methoxy-2-octyl-3-oxopropyl)phenazine-1-carboxylate

methyl 6-(1-hydroxy-3-methoxy-2-octyl-3-oxopropyl)phenazine-1-carboxylate

C26H32N2O5 (452.2311)